Astellas provides funding for US cell and gene therapy biotechs
Astellas to fund two biotech incubators, operated by LabCentral, to cultivate start-up companies focused on cell and gene therapies.
Archives for October 3, 2019
Lonza in deal to manufacture Cellectis’ UCART oncology pipeline
Cellectis chooses Lonza to take on the clinical manufacturing of its UCART blood cancer immunotherapy candidates, intended to be marketed as industrialized, readily available CAR-T cells.